🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Fibroblast-activation protein (FAP) is a type Ⅱ transmembrane serine protea...
Status
Recruiting
Location
Zhongnan Hospital of Wuhan University
Start Date
2021-02-23
Trial ID
NCT05034146
Non-alcoholic fatty liver disease (NAFLD), estimated to be 17% prevalent in...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-09-01
Trial ID
NCT06160271
Treatments Being Tested
Fibroblast activation protein (FAP) is overexpressed in cancer-associated f...
Status
Unknown
Location
Peking Union Medical College Hospital
Start Date
2021-05-01
Trial ID
NCT05574907
Treatments Being Tested
The aim of this trial is to investigate the value of FAPI PET/MRI, FDG PET/...
Status
Recruiting
Location
first hospital affiliated of Fujian medical university
Start Date
2024-08-02
Trial ID
NCT06421142
Treatments Being Tested
Sjögren's syndrome (SS) is a chronic autoimmune disease primarily affecting...
Status
Recruiting
Location
Peking Union Medical College Hospital
Start Date
2024-07-01
Trial ID
NCT07062523
Treatments Being Tested
68Ga-FAPI has been developed as a tumor-targeting agent as fibroblast activ...
Status
Unknown
Location
Peking Union Medical College Hospital
Start Date
2020-09-01
Trial ID
NCT04514614
Treatments Being Tested
In this work, we address the understanding of the signaling pathways involv...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-01-01
Trial ID
NCT07351136
Treatments Being Tested
To evaluate the potential usefulness of 68Ga-DOTA/NOTA-FAPI-04 positron emi...
Status
Recruiting
Location
The First Affiliated Hospital of Fujian Medical University
Start Date
2020-08-15
Trial ID
NCT04499365
Treatments Being Tested
This study is a prospective exploratory study to explore the application va...
Status
Recruiting
Location
Peking Union Medical College Hospital
Start Date
2024-03-01
Trial ID
NCT06774209
Treatments Being Tested
Keloid scars are common benign fibroproliferative reticular dermal lesions....
Status
Completed
Location
Peking Union Medical College Hospital
Start Date
2022-03-01
Trial ID
NCT05275699
Treatments Being Tested